Blockchain technology has the potential to improve trust, transparency, patient safety and patient empowerment in clinical trials
Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials
Reach Me
Request a Call Back by filling out and submitting the following form.
+1 408-568-3993